Volume 32, Issue 6 (September 2021)
Studies in Medical Sciences 2021, 32(6): 428-436 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aryaei F, Firoozrai M, Kalbasi S. THE FREQUENCY OF RS877899 POLYMORPHISMS IN THE SEPP1 GENES AND TYPE 2 DIABETES, ITS RELATION TO BLOOD GLUCOSE LEVELS AND BLOOD SELENOPROTEINE P AND OXIDATIVE STRESS INDICES. Studies in Medical Sciences 2021; 32 (6) :428-436
URL: http://umj.umsu.ac.ir/article-1-5458-en.html
URL: http://umj.umsu.ac.ir/article-1-5458-en.html
Professor, Clinical Biochemistry Department, Medical Faculty, Sharood Azad Islamic University, Shahrood, Iran (Corresponding Author) , firoozraim@yahoo.com
Abstract: (2596 Views)
Background & Aims: Ala234Thr single nucleotide polymorphism can affect the level of oxidative stress capacity and serum selenium levels. On the other hand, blood glucose and insulin levels regulate the expression of SEPP1 gene. It is hypothesized that this polymorphism may be significantly associated with diabetes. The aim of this study was to determine the genotype of Ala234Thr polymorphism in patients with type 2 diabetes and its effect on glucose levels, selenoprotein p levels, and oxidative stress status of patients.
Materials & Methods: In this study, biochemical indices (FBS & HbA1C), and serum oxidative stress indices (MDA and total antioxidant capacity) were measured in both patient and healthy groups, and Tetra-ARMS PCR was used to determine the genotype of A234T polymorphism.
Results: There was no significant relationship between demographic indicators (age and gender) with the incidence of type 2 diabetes, but there was a significant relationship between biochemical indicators and oxidative stress (p = 0.001). Genotyping results showed that the frequency of GG genotype in the control group was higher than the patient group, but it was not statistically significant. It was also found that the risk of type 2 diabetes in people with GA genotype is 2.14 times higher than others (p = 0.035).
Conclusion: The results demonstrated the effect of high levels of SEPP1 on the pathogenesis of type 2 diabetes through oxidative stress pathways. Rs3877899 polymorphism is associated with an increased risk of type 2 diabetes in the subjects.
Materials & Methods: In this study, biochemical indices (FBS & HbA1C), and serum oxidative stress indices (MDA and total antioxidant capacity) were measured in both patient and healthy groups, and Tetra-ARMS PCR was used to determine the genotype of A234T polymorphism.
Results: There was no significant relationship between demographic indicators (age and gender) with the incidence of type 2 diabetes, but there was a significant relationship between biochemical indicators and oxidative stress (p = 0.001). Genotyping results showed that the frequency of GG genotype in the control group was higher than the patient group, but it was not statistically significant. It was also found that the risk of type 2 diabetes in people with GA genotype is 2.14 times higher than others (p = 0.035).
Conclusion: The results demonstrated the effect of high levels of SEPP1 on the pathogenesis of type 2 diabetes through oxidative stress pathways. Rs3877899 polymorphism is associated with an increased risk of type 2 diabetes in the subjects.
References
1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017;389(10085):2239-51. [DOI:10.1016/S0140-6736(17)30058-2]
2. Edelman SV, Polonsky WH. Type 2 diabetes in the real world: the elusive nature of glycemic control. Diabetes Care 2017;40(11):1425-32. [DOI:10.2337/dc16-1974] [PMID]
3. Goodarzi M, Ebrahimzadeh I, Rabi A, Saedipoor B, Jafarabadi MA. Impact of distance education via mobile phone text messaging on knowledge, attitude, practice and self efficacy of patients with type 2 diabetes mellitus in Iran. J Diabetes Metab Disord2012;11(1):10. [DOI:10.1186/2251-6581-11-10] [PMID] [PMCID]
4. Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes 2015;39(1):44-9. [DOI:10.1016/j.jcjd.2014.03.002] [PMID]
5. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295(14):1681-7. [DOI:10.1001/jama.295.14.1681] [PMID]
6. Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res2011;8(1):22-8. [DOI:10.1177/1479164110390243] [PMID]
7. Sordillo LM. Selenium-dependent regulation of oxidative stress and immunity in periparturient dairy cattle. Vet Med Int 2013;2013:154045. [DOI:10.1155/2013/154045] [PMID] [PMCID]
8. Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003;133(5):1517S-20S. [DOI:10.1093/jn/133.5.1517S] [PMID]
9. Burk RF, Hill KE. Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 2009;1790(11):1441-7. [DOI:10.1016/j.bbagen.2009.03.026] [PMID] [PMCID]
10. Mao J, Teng W. The relationship between selenoprotein P and glucose metabolism in experimental studies. Nutrients 2013;5(6):1937-48. [DOI:10.3390/nu5061937] [PMID] [PMCID]
11. Akbaba G, Akbaba E, Sahin C, Kara M. The relationship between gestational diabetes mellitus and selenoprotein-P plasma 1 (SEPP1) gene polymorphisms. Gynecol Endocrinol 2018;34(10):849-52. [DOI:10.1080/09513590.2018.1460659] [PMID]
12. Mita Y, Nakayama K, Inari S, Nishito Y, Yoshioka Y, Sakai N, et al. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nat Commun 2017;8(1):1-7. [DOI:10.1038/s41467-017-01863-z] [PMID] [PMCID]
13. Foster CB, Aswath K, Chanock SJ, McKay HF, Peters U. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC genetics 2006;7(1):56. [DOI:10.1186/1471-2156-7-56] [PMID] [PMCID]
14. Karunasinghe N, Han DY, Zhu S, Yu J, Lange K, Duan H,et al. Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Gene NuTr 2012;7(2):179-90. [DOI:10.1007/s12263-011-0259-1] [PMID] [PMCID]
15. Saito Y. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. J Clin Biochem Nutr 2019:19-31. [Google Scholar]
16. Speckmann B, Sies H, Steinbrenner H. Attenuation of hepatic expression and secretion of selenoprotein P by metformin. Biochem Biophys Res Commun 2009;387(1):158-63. [DOI:10.1016/j.bbrc.2009.06.143] [PMID]
17. Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005;25:215-35. [DOI:10.1146/annurev.nutr.24.012003.132120] [PMID]
18. Degirmencioglu S, Tütenº A, Yükselº MA, Yılmaz N, Gulyasarº T, Yıldız M, et al. The role of selenoprotein P and selenium in the etiopathogenesis of gestational diabetes mellitus: Association with selenoprotein P1 gene (rs3877899) polymorphism. Trace Elem Electrolytes 2018;35(4):174-82. [DOI:10.5414/TEX01527]
19. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004;122(4):333-8. [DOI:10.1007/s00418-004-0678-9] [PMID]
20. Donadio JL, Rogero MM, Guerra-Shinohara EM, Desmarchelier C, Borel P, Cozzolino SM. SEPP1 polymorphisms modulate serum glucose and lipid response to Brazil nut supplementation. Eur J Nutr 2018;57(5):1873-82. [DOI:10.1007/s00394-017-1470-7] [PMID]
21. Gharipour M, Ouguerram K, Nazih EH, Salehi M, Behmanesh M, Razavi R, et al. Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease. Mol Biol Rep 2019;46(6):5685-93. [DOI:10.1007/s11033-019-05000-5] [PMID]
22. Steinbrenner H, Hotze AL, Speckmann B, Pinto A, Sies H, Schott M, et al. Localization and regulation of pancreatic selenoprotein P. J Mol Endocrinol 2013;50(1):31-42. [DOI:10.1530/JME-12-0105] [PMID]
23. Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, Saito Y, et al. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PloS one 2012;7(4):e34952. [DOI:10.1371/journal.pone.0034952] [PMID] [PMCID]
24. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96(8):E1325-9. [DOI:10.1210/jc.2011-0620] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
